Unilateral Cutaneous Ureterostomy

See also
Status	Clinical Trial	Phase
Completed	`NCT01029015` - Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects	Phase 4
Terminated	`NCT01099345` - A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)	N/A
Recruiting	`NCT05786391` - Trendelenburg, Abdominal Insufflation and Time to Completion of Cystoscopy	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT01029015 - Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects

Phase 4

Terminated

NCT01099345 - A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)

N/A

Recruiting

NCT05786391 - Trendelenburg, Abdominal Insufflation and Time to Completion of Cystoscopy

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00546208
Study type	Observational
Source	Sheba Medical Center
Contact	Dorit E Zilberman, MD
Phone	+97235302231
Email	dorit.zilberman@sheba.health.gov.il
Status	Recruiting
Phase	N/A
Start date	February 2008

Unilateral Cutaneous Ureterostomy - Long Term Follow up — ureterostomy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms